Josh4580

Hey everyone, I need some help on this stock. I am wondering if anyone here still owns any HRTPY (Petro Rio). The company's ADR was delisted on January 27th, 2017. See the PR below: https://www.newswire.ca/news-releases/petrorio---delisting-from-tsx-v-in-connection-with-termination-of-gds-program-608620685.html I tried to open a Brazilian brokerage account but its basically impossible (IBKR doesnt offer Brazil trading believe it or not). So I decided to just let DB sell the stock for me and get the proceeds. Its been almost a year since the stock was delisted. The last price HRTPY traded at was $3.86. That day the Brazilian stock (PRIO3.SA) traded at 27.59 BRL. The stock has since increased to 95.90 BRL, a 247% increase. In the press release it states: "In the absence of written instructions from the GDS holders or their agents by the end of such four month period as to how the underlying Common Shares are to be delivered to a valid brokerage account, such Common Shares to which the former GDS holder was entitled will be sold in the market by Deutsche Bank and the net proceeds remitted to the former GDS holder." So far its been a year and I have not received any distribution nor has any of my friends or family that also own the stock. As per this message board, DB has not sold any shares yet. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137355699 FYI...I just called Deutsche Bank in New York and they stated that the GDS shares have yet to be sold. They were hoping for a sale before the end of 2017 but that did not happen. He told me to keep calling back to check...212-250-9100. What are your guys opinions as to what is going on here and what type of distribution I can expect? Thanks!

https://biz.yahoo.com/e/160418/felp8-k.html On April 18, 2016, Foresight Energy LLC ("FELLC") and Foresight Energy LP (together with FELLC and certain subsidiaries of FELLC, the "Partnership") entered into a Transaction Support Agreement (the "Support Agreement"), with certain of the lenders (the "Consenting Lenders") under the Partnership's Second Amended and Restated Credit Agreement dated as of August 23, 2013 (the "Credit Agreement"), pursuant to which the Consenting Lenders have agreed (subject to the terms and conditions set forth therein) to support a proposed global restructuring of the Partnership's indebtedness (the "Restructuring"), including a proposed amendment and restatement (the "Amendment") of the Credit Agreement.

Barrons failed to deliver to me twice already this year.

up 28% today any rumors or reasons why?

RVXCF now up 240% to $2.31 per share from original $0.68 write up price. They signed a licensing and equity deal with Shenzhen Hepalink "The deal structure involves CAD$50 million in equity investments, and future China sales milestones and licensing royalties that could represent in excess of US$400 million" http://finance.yahoo.com/news/resverlogix-china-based-shenzhen-hepalink-110000218.html Company is in talks to sell itself to a large pharma company: Resverlogix CEO Says Company in Discussions to Be Bought http://www.bloomberg.com/news/articles/2015-04-28/resverlogix-ceo-says-company-in-discussions-to-be-bought “We are in discussions with multiple companies, not just one,” Donald McCaffrey, CEO of Calgary-based Resverlogix, said in a phone interview “We see ourselves as a potential acquisition target,” McCaffrey said. “We are tightly controlled, so we wouldn’t let it go at anywhere near the rates we’re at right now.” I still think this one has lots of upside to go.

http://finance.yahoo.com/q?s=rvxcf&fr=uh3_finance_web&uhb=uhb2 RVXCF is now up 100% since I first posted about it last year at $0.68. There was a great research report put out today by this research analyst Marcel Wijma. I have attached the report to this post. As seen below, his DCF analysis gets to a value of CAD 5.85 or $4.61 USD. "We value RVX-208, and thereby Resverlogix as a whole at CAD 500 million or CAD 5.85 per share. This is based on a risk-adjusted net present value analysis of income from RVX-208. RVX-208 clearly has blockbuster potential. We choose not to value the company’s total technology platform and potential additional indications for RVX-208 and therefore only to make a valuation of the current clinical pipeline of RVX-208. We feel that potential value of its platform and additional indications offers an additional upside potential. With the start of a large Phase III clinical trial we estimate a probability of success of 54%. This is based on an independent survey executed by BioMedTracker and BIO in 20121. " I continue to believe this is a great risk/reward at $1.36 per share. Leeuwenhoeck_RVX_Initiating_Coverage_$5.85_PT.pdf

This is exactly what is going on at Weight Watchers (WTW)!

Started buying this stock at $2.50 with an average price around $3. Up around 35% today to $3.78. Barrons article today basically sums up my whole thesis so here is the link: http://online.barrons.com/news/articles/SB51367578116875004693704580500021807004844?mod=yahoobarrons&ru=yahoo Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1989673 Standard of care right now for MF is Jakafi which only addresses the side-effects and doesn't put the cancer into remission. Imetelstat actually puts the disease into remission. Jakafi is owned by Incyte, which has a market cap of $15.80 billion, mainly from this drug. Geron's market cap is $594 million. Thoughts?

http://finance.yahoo.com/q?s=RVXCF Resverlogix up 28% today on decent volume. Finally back over my initial post price of $0.68. This is my favorite risk/reward for 2015. The next best would be Fannie/Freddie preferreds

Atlas Energy Announces Record And Distribution Dates For Spin-Off Of Atlas Energy Group, LLC http://phx.corporate-ir.net/phoenix.zhtml?c=197317&p=irol-newsArticle&ID=2011459 Atlas Energy, L.P. Announces Distribution Of $0.52 For The Fourth Quarter 2014 http://phx.corporate-ir.net/phoenix.zhtml?c=197317&p=irol-newsArticle&ID=2011458 PITTSBURGH, Jan. 28, 2015 /PRNewswire/ -- Atlas Energy, L.P. (NYSE: ATLS) today declared a quarterly distribution for the fourth quarter 2014 of $0.52 per common unit. The fourth quarter 2014 distribution is payable Thursday, February 19, 2015 to holders of record as of Monday, February 9, 2015.

Hey it was great meeting all you guys yesterday. I had a lot of fun. Zizou thanks for organizing. We should meet up again later in the year.

http://www.bloomberg.com/news/2015-01-22/petrorio-has-biggest-gain-after-buying-shell-project.html?cmpid=yhoo "PetroRio SA (HRTP3), the company formerly known as HRT Participacoes em Petroleo SA, had its biggest intraday gain after agreeing to buy an 80 percent stake in a Royal Dutch Shell Plc project in Brazil." HRTP3 is trading at 6 BRL today. HRTPY is currently halted at $0.60 The fair value right now of HRTPY is $1.17 minus any discount for ADS fees. Lets see where it starts trading.

http://edge.media-server.com/m/p/5wz2z9gn http://www.resverlogix.com/media/press-release.html?id=512#.VLqJKIrF-Dg Resverlogix announced their Phase 3 trial design (BETonMACE trial) at the 2015 Biotech Showcase for RVX-208. This should pave the way for a partnership with Big Pharma.

I ran some numbers in regards to this new financing with Galena. Mawson West Financing and Debt Restructure Presentation http://www.mawsonwest.com/IRM/Company/ShowPage.aspx/PDFs/1665-97469649/MawsonWestFinancingandDebtRestructure According to the reserve update (http://www.mawsonwest.com/IRM/Company/ShowPage.aspx/PDFs/1664-30732455/KapuloMineralReservesUpdate), MWE is estimating 122,000 tonnes of copper will be recovered from Kapulo over a mine life of 6.3 years. The estimated cash cost per pound is $1.92, or $4,233 per tonne. Using the current copper price of $6,445 (https://www.lme.com/metals/non-ferrous/copper/#tab2) and an estimated tax rate of 36%, I am calculating the total after tax cash flow to be $172.72 million. This equates to an average annual after tax cash flow of $27.465 million over the 6.3 year mine life. Using a discount rate of 15%, I calculate a NPV of $107 million. According to page 5 of the presentation on the Galena financing, there will be a maximum of 484.8 million diluted shares outstanding. This still gets me to a value of Kapulo of 22 cents per share. The current stock price is $0.055 CAD. Seems like there is still some decent upside here. Additionally, the reserves at Kapulo are now 86% proven.

http://www.mawsonwest.com/IRM/Company/ShowPage.aspx/PDFs/1666-65160422/US334MillionFinancingandDebtRestructuringPackage US$33.4 Million Financing and Debt Restructuring Package